CMS Open Payments · Program Year 2024
Veryan Medical Incorporated
Veryan Medical Incorporated reported $525,920.03 across General Payments, Research, and Ownership to 278 physicians and teaching hospitals across 363 transactions.
- $525.9K Above-median payer
- All-tracks total
- 363 Above-median volume
- Transactions
- 278 Above-median reach
- Recipients
- +$239.9K
- General Payments vs PY2023
Veryan Medical Incorporated reported $525,920.03 across all CMS Open Payments tracks (General + Research + Ownership) to 278 physicians and teaching hospitals in Program Year 2024 - ranking #748 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $359,172.86, averaging $1.9K per recipient.
How Veryan Medical Incorporated's $525.9K all-tracks total breaks down
Veryan Medical Incorporated's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
23/100
Total payments
F
15/100
Transaction volume
F
13/100
Physician reach
F
12/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer veryan-medical-incorporated Veryan Medical Incorporated
$525.9K · #748/1,925 · 0.0% industry · PY2024
- TOT $525.9K
- RANK #748
- SHARE 0.0%
- TXN 363
- RCP 278
- CAT 4
- GEN $359.2K
- ΔGEN +$239.9K
- TOP1 91.4%
- PY 2024
Volume peers
Nearest volume peer: GC America Inc. ($524.2K)
Veryan Medical Incorporated sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Veryan Medical Incorporated's CMS-reported General Payments increased by $239.9K (+201.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: VERYAN MEDICAL INCORPORATEDPY2023: VERYAN MEDICAL INCORPORATEDPY2024: Veryan Medical Incorporated. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $119,278.35
- PY2024
- $359,172.86
What the Data Shows for Veryan Medical Incorporated
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Veryan Medical Incorporated, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $273.4K, accounting for 76.1% of this company's General Payments and 19 transactions.
General Payment Breakdown by Type
Veryan Medical Incorporated made 4 types of general payments. "Consulting Fee" is the largest category at $273.4K, 76.1% of General Payments.
Veryan Medical Incorporated reports 4 general-payment categories - the top three are Consulting Fee (76.1%), Travel and Lodging (19.2%), and Food and Beverage (4.4%). The remaining 1 category make up 0.2% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Veryan Medical Incorporated divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $273.4K | 19 | 76.1% |
| Travel and Lodging | $69.0K | 34 | 19.2% |
| Food and Beverage | $15.9K | 224 | 4.4% |
| Compensation for Services Other Than Consulting | $843.09 | 1 | 0.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $344,946.88 (96.0%) of $359,172.86 in this company's General Payments records across 144 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Veryan Medical Incorporated
The five named recipients with the highest reported General Payments from this company
- 1
Bret N Wiechmann
$328,311.70 across 65 reported transactions
- 2
Eric Secemsky
$7,000.00 across 2 reported transactions
- 3
Mark Conrad
$5,000.00 across 2 reported transactions
- 4
Nicholas Mouawad
$3,750.00 across 2 reported transactions
- 5
Gary Ansel
$885.18 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Veryan Medical Incorporated ranks #748 of 1,925 by total payments (top 39% by spend) but is notably more concentrated than that alone would suggest -- #191 of 1,838 by HHI (top 10% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Xiros Inc : $3.4K total payments, HHI 8644
- Emmaus Medical, Inc. : $197.9K total payments, HHI 8631
- OrthoPediatrics Canada ULC : $104.0K total payments, HHI 8624
- Sequoia Surgical Distributors, LLC : $65.8K total payments, HHI 8574
- Auxano Medical LLC : $8.8K total payments, HHI 8543
- Swan Valley Medical Incorporated : $65.3K total payments, HHI 8507
- Veryan Medical Incorporated (this company) : $359.2K total payments, HHI 8362
- Poriferous LLC : $7.6K total payments, HHI 8281
- Myocardial Solutions, Inc. : $4.2K total payments, HHI 8121
- Immucor, Inc. : $601.94 total payments, HHI 8069
- Bridge to Life Ltd : $5.6K total payments, HHI 7946
- Cortigent Inc : $4.9K total payments, HHI 7844
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Veryan Medical Incorporated's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Veryan Medical Incorporated.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Veryan Medical Incorporated.
Showing 6 of 1,924 companies with CMS-reported payment data.
Astellas Pharma Europe Ltd
OraSure Technologies Inc.
Dynavax Technologies Corporation
Genesis Software Innovations, LLC
Pulse Biosciences, Inc.
Put this to use
Veryan Medical Incorporated ranks #748 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Veryan Medical Incorporated. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.